Published in BMJ on May 21, 1994
Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig (2010) 10.98
Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ (2001) 3.48
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care (2010) 3.12
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med (2012) 2.75
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol (2014) 2.19
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med (2007) 2.04
Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care (2010) 1.95
The pros and cons of diagnosing diabetes with A1C. Diabetes Care (2011) 1.79
Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes (2010) 1.53
Glycated haemoglobin in the year 2000. J Clin Pathol (2000) 1.52
Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J Pediatr (2010) 1.45
Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis (2011) 1.45
Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med (1997) 1.36
Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med (2011) 1.30
How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level? Diabetologia (2006) 1.14
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia (2012) 1.11
HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care (2014) 1.06
Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study. Arch Ophthalmol (2011) 1.05
Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. CMAJ (2005) 1.04
The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. Diabetes Care (2011) 1.03
The changing classification and diagnosis of diabetes. New classification is based on pathogenesis, not insulin dependence. BMJ (1998) 1.02
New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes (2012) 1.01
Evaluation for fasting and 2-hour glucose and HbA1c for diagnosing diabetes based on prevalence of retinopathy in a Chinese population. PLoS One (2012) 1.00
Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care (2011) 0.96
Guidelines for the detection of diabetes mellitus--diagnostic criteria and rationale for screening. Clin Biochem Rev (2003) 0.96
An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health (2008) 0.95
Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol (2014) 0.95
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. CMAJ (1999) 0.89
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes (2013) 0.88
The relationship of body mass index and waist-hip ratio on the 9-year incidence of diabetes and hypertension in a predominantly African-origin population. Ann Epidemiol (2008) 0.88
The Utility of HbA1c as a Diagnostic Criterion of Diabetes. Korean J Fam Med (2011) 0.85
New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies. Clin J Am Soc Nephrol (2008) 0.82
Prevalence of diabetes mellitus in the elderly of Namwon County, South Korea. Korean J Intern Med (2002) 0.82
Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference. Diabetes Care (2016) 0.81
7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8-10, 2014, Helsinki, Finland. Diabetes Technol Ther (2014) 0.80
Topics in type 2 diabetes and insulin resistance. Diabetes Care (2009) 0.80
Offspring birth weight, gestational age and maternal characteristics in relation to glucose status at age 53 years: evidence from a national birth cohort. Diabet Med (2008) 0.79
Rehabilitative considerations for dental implants in the diabetic patient. J Indian Prosthodont Soc (2012) 0.77
Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast. J Clin Biochem Nutr (2009) 0.77
Longitudinal validation of hemoglobin A(1c) criteria for diabetes diagnosis: risk of retinopathy. Diabetes (2012) 0.77
Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey. Diabetes Metab J (2016) 0.77
Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk. Nat Rev Cardiol (2010) 0.76
Hemoglobin A1c Level Is Not Related to the Severity of Atherosclerosis in Patients with Acute Coronary Syndrome. Dis Markers (2015) 0.76
Relationship between Stage of Diabetic Retinopathy and Pulse Wave Velocity in Japanese Patients with Type 2 Diabetes. J Diabetes Res (2013) 0.75
New ADA criteria in the Korean population: fasting blood glucose is not enough for diagnosis of mild diabetes especially in the elderly. Korean J Intern Med (2000) 0.75
Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World J Diabetes (2016) 0.75
The Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese Population. J Diabetes Res (2016) 0.75
Tests for diagnosing diabetes mellitus. Methods for estimating glycated haemoglobin differ. BMJ (1994) 0.75
Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study. J Diabetes Res (2015) 0.75
Diagnosis and management of diabetes and the relationship of dglucose to kidney function. Curr Diabetes Rev (2015) 0.75
Type 2 diabetes and edentulism as chronic co-morbid factors affecting Indian elderly: an overview. J Indian Prosthodont Soc (2013) 0.75
Tests for diagnosing diabetes mellitus. Glucose tolerance test is most sensitive. BMJ (1994) 0.75
Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population. Iran Red Crescent Med J (2016) 0.75
Tests for diagnosing diabetes mellitus. Extrapolation of findings is incorrect. BMJ (1994) 0.75
Evidence for current diagnostic criteria of diabetes mellitus. World J Diabetes (2016) 0.75
The Accuracy of Diagnostic Methods for Diabetic Retinopathy: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.75
HbA1c and the Prediction of Type 2 Diabetes in Children and Adults. Diabetes Care (2016) 0.75
Tests for diagnosing diabetes mellitus. Measuring glycated haemoglobin concentration is acceptable. BMJ (1994) 0.75
The optimal cutoff value of glycated hemoglobin for detection of diabetic retinopathy. Diabetes Metab J (2015) 0.75
HbA1c as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus. Sci Rep (2016) 0.75
Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration. J Diabetes Res (2016) 0.75
Protective effect of Monascus fermented rice against STZ-induced diabetic oxidative stress in kidney of rats. J Food Sci Technol (2013) 0.75
Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis. PLoS Negl Trop Dis (2017) 0.75
Tools for practice: screening and diagnosis of type 2 diabetes with HbA1c. Can Fam Physician (2013) 0.75
Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers. Springerplus (2015) 0.75
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
The early recognition of diabetes mellitus. Ann N Y Acad Sci (1959) 3.94
Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev (1990) 3.64
Hyperglycaemia and diabetes mellitus. Lancet (1976) 3.57
Glucose tolerance; a comparison of four types of diagnostic tests in 103 control subjects and 26 patients with diabetes. Am J Med Sci (1950) 2.87
Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet (1980) 2.64
Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin Chem (1980) 2.24
Diabetes in the Pima Indians. Evidence of bimodality in glucose tolerance distributions. Diabetes (1971) 1.71
Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians. Diabetologia (1979) 1.62
Bimodality of fasting and two-hour glucose tolerance distributions in a Micronesian population. Diabetes (1978) 1.55
Comparison of the value of the two- and one-hour glucose levels of the oral GTT in the diagnosis of diabetes in Pima Indians. Diabetes (1975) 1.33
Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med (1993) 1.29
An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1c. Clin Chem (1984) 1.27
Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int (1989) 1.19
Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study. J Chronic Dis (1985) 1.18
Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol (1984) 1.15
Hemoglobin A1c levels in a diabetes detection program. J Clin Endocrinol Metab (1978) 1.14
The link between hyperglycaemia and diabetic nephropathy. Diabetologia (1992) 1.10
Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia (1993) 1.05
Bimodality in glucose tolerance distributions in the urban Polynesian population of Western Samoa. Diabetes Res (1984) 1.02
Comparison of glycosylated hemoglobin and fasting plasma glucose with two-hour post-load plasma glucose in the detection of diabetes mellitus. Am J Epidemiol (1985) 0.99
Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus--an assessment of the criteria of the WHO Expert Committee on Diabetes Mellitus 1980. Ann Clin Biochem (1985) 0.99
Screening for diabetes mellitus. Ann Intern Med (1988) 0.97
Early detection and intervention in diabetes mellitus: is it effective? J Chronic Dis (1984) 0.96
The relationship between glycosylated haemoglobin levels and various degrees of glucose intolerance. Diabetologia (1983) 0.96
Glycosylated haemoglobin as an alternative to the glucose tolerance test for the diagnosis of diabetes mellitus. Ann Clin Biochem (1985) 0.95
Glycosylated hemoglobin assay and oral glucose tolerance test compared for detection of diabetes mellitus. Clin Chem (1979) 0.94
Limitations of the oral glucose tolerance test in diagnosis of early diabetes. Prim Care (1977) 0.93
Bimodality of glycosylated hemoglobin distribution in Pima Indians: relationship to fasting hyperglycemia. Diabetes (1979) 0.93
Four assay methods for glycated hemoglobin compared as screening tests for diabetes mellitus: the Islington Diabetes Survey. Clin Chem (1988) 0.93
Two commercial methods evaluated for eliminating the labile fraction from the assay for glycated hemoglobin (glycohemoglobin). Clin Chem (1984) 0.89
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes (1997) 8.96
The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care (2000) 7.41
Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet (1988) 7.00
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr (2000) 6.82
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes (2000) 5.83
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med (1999) 5.59
Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22
Amerindian mitochondrial DNAs have rare Asian mutations at high frequencies, suggesting they derived from four primary maternal lineages. Am J Hum Genet (1990) 5.17
Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med (1996) 5.17
Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes (1987) 4.86
Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics (1992) 4.78
Dramatic founder effects in Amerindian mitochondrial DNAs. Am J Phys Anthropol (1985) 4.56
Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care (1990) 4.49
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87
Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev (1990) 3.64
Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care (1991) 3.51
Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41
Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (1998) 3.37
The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med (1988) 3.36
Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30
Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19
An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet (1998) 3.16
Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation (2001) 3.12
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01
Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes (1988) 3.00
Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol (1981) 2.97
Gestational diabetes mellitus. JAMA (2001) 2.90
Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ (1994) 2.67
Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet (1980) 2.64
Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med (1983) 2.60
Increasing prevalence of Type II diabetes in American Indian children. Diabetologia (1998) 2.57
Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia (1999) 2.55
Body mass index as a measure of adiposity in children and adolescents: relationship to adiposity by dual energy x-ray absorptiometry and to cardiovascular risk factors. J Clin Endocrinol Metab (2001) 2.52
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.46
Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet (1997) 2.45
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol (2001) 2.45
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43
Is a low leptin concentration, a low resting metabolic rate, or both the expression of the "thrifty genotype"? Results from Mexican Pima Indians. Am J Clin Nutr (1998) 2.42
Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med (1980) 2.37
Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25
The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol (1999) 2.20
An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18
Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med (1970) 2.16
Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care (1994) 2.15
Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care (2000) 2.14
Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care (1980) 2.12
GM allotypes in Native Americans: evidence for three distinct migrations across the Bering land bridge. Am J Phys Anthropol (1985) 2.11